Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Barac

Showing results (81-90 of 167) with videos related to

Pageof 17
Sort By:
Medrxiv : the Preprint Server for Health Sciences|February 27, 2024
Timing of Regadenoson-induced Peak Hyperemia and the Effects on Coronary Flow ReserveNathan Kattapuram, Shahrad Shadman, Eric E Morgan, et al.
Circulation|June 15, 2026
Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities: A Scientific Statement From the American Heart AssociationAna Barac, Avirup Guha, Thomas R Fleming, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2026
Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities: A Scientific Statement From the American Heart AssociationAna Barac, Avirup Guha, Thomas R Fleming, et al.
Contemporary Clinical Trials Communications|January 15, 2025
Comorbidities And Reducing InEquitieS (CARES): Feasibility of self-monitoring and community health worker support in management of comorbidities among Black breast and prostate cancer patientsLaura C Schubel, Ana Barac, Michelle Magee, et al.
JAMA Cardiology|July 5, 2018
Association of APOL1 With Heart Failure With Preserved Ejection Fraction in Postmenopausal African American WomenNora Franceschini, Jeffrey B Kopp, Ana Barac, et al.
Circulation|September 21, 2023
Cardiovascular Imaging in Contemporary Cardio-Oncology: A Scientific Statement From the American Heart AssociationDaniel Addison, Tomas G Neilan, Ana Barac, et al.
Cancer Research Communications|June 4, 2025
Real-world Data on Risk Factors for Emergency Department Visits to Treat Outpatient Chemotherapy-Associated ToxicitiesSanja Karovic, Erik Dvergsten, Chiara Pierattini, et al.
Journal of Cancer Survivorship : Research and Practice|February 5, 2025
Relationship between incident cardiovascular disease and quality of life after a breast cancer diagnosisAlexi Vasbinder, Elena Wadden, Richard K Cheng, et al.
Circulation|February 22, 2019
Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement From the American Heart AssociationUmberto Campia, Javid J Moslehi, Laleh Amiri-Kordestani, et al.
JAMA|November 13, 2019
Association of Cardiac Resynchronization Therapy With Change in Left Ventricular Ejection Fraction in Patients With Chemotherapy-Induced CardiomyopathyJagmeet P Singh, Scott D Solomon, Michael G Fradley, et al.
Pageof 17

Showing results (81-90 of 167) with videos related to

Sort By:
Pageof 17
Medrxiv : the Preprint Server for Health Sciences|February 27, 2024
Timing of Regadenoson-induced Peak Hyperemia and the Effects on Coronary Flow ReserveNathan Kattapuram, Shahrad Shadman, Eric E Morgan, et al.
Circulation|June 15, 2026
Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities: A Scientific Statement From the American Heart AssociationAna Barac, Avirup Guha, Thomas R Fleming, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2026
Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities: A Scientific Statement From the American Heart AssociationAna Barac, Avirup Guha, Thomas R Fleming, et al.
Contemporary Clinical Trials Communications|January 15, 2025
Comorbidities And Reducing InEquitieS (CARES): Feasibility of self-monitoring and community health worker support in management of comorbidities among Black breast and prostate cancer patientsLaura C Schubel, Ana Barac, Michelle Magee, et al.
JAMA Cardiology|July 5, 2018
Association of APOL1 With Heart Failure With Preserved Ejection Fraction in Postmenopausal African American WomenNora Franceschini, Jeffrey B Kopp, Ana Barac, et al.
Circulation|September 21, 2023
Cardiovascular Imaging in Contemporary Cardio-Oncology: A Scientific Statement From the American Heart AssociationDaniel Addison, Tomas G Neilan, Ana Barac, et al.
Cancer Research Communications|June 4, 2025
Real-world Data on Risk Factors for Emergency Department Visits to Treat Outpatient Chemotherapy-Associated ToxicitiesSanja Karovic, Erik Dvergsten, Chiara Pierattini, et al.
Journal of Cancer Survivorship : Research and Practice|February 5, 2025
Relationship between incident cardiovascular disease and quality of life after a breast cancer diagnosisAlexi Vasbinder, Elena Wadden, Richard K Cheng, et al.
Circulation|February 22, 2019
Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement From the American Heart AssociationUmberto Campia, Javid J Moslehi, Laleh Amiri-Kordestani, et al.
JAMA|November 13, 2019
Association of Cardiac Resynchronization Therapy With Change in Left Ventricular Ejection Fraction in Patients With Chemotherapy-Induced CardiomyopathyJagmeet P Singh, Scott D Solomon, Michael G Fradley, et al.
Pageof 17